title: Gout.
abstract: Gout is a common disease in the primary health care setting. Diagnosis of primary gout is definite if urate crystals are present in synovial fluid or tophi. The colchicine therapeutic trial is a useful diagnostic aid but not specific. Secondary gout is associated with myeloproliferative disease. Non-steroidal anti-inflammatory agents or colchicine are the main stays of treatment in acute gouty arthritis. In the inter-critical period, uricosuric agents or allopurinol can be used to control hyperuricaemia. Allopurinol is the treatment of choice in secondary gout. Asymptomatic hyperuricaemia is not an indication for therapy.
authors.affiliation: Department of Rheumatology and Immunology, Tan Tock Seng Hospital, Singapore.
authors.forename: K H
authors.initials: KH
authors.lastname: Leong
authors.forename: P H
authors.initials: PH
authors.lastname: Feng
mesh_terms: D000328:Adult; D000368:Aged; D015210:Arthritis, Gouty / Q000175:diagnosis* / Q000209:etiology / Q000628:therapy; D005260:Female; D006073:Gout / Q000175:diagnosis* / Q000209:etiology / Q000628:therapy; D006801:Humans; D008297:Male; D008875:Middle Aged; D014527:Uric Acid / Q000097:blood
chemical_list: D014527:Uric Acid